Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

DOLOVANZ FORTE 25 MG SOLUCIÓN ORAL - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/DOLOVANZ FORTE 25 MG SOLUCIÓN ORAL

Approved

STANDARD

DOLOVANZ FORTE 25 MG SOLUCIÓN ORAL

Laboratorios Cinfa S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jun 12, 2023
Approval ID: 88e78556ba8e1c92
Company: Laboratorios Cinfa S.A.
Type: Standard

Approval Details

Approval Id: 88e78556ba8e1c92
Drug Cima Aemps Name: DOLOVANZ FORTE 25 MG SOLUCIÓN ORAL
Register Number: 88900
Holder Company Name: Laboratorios Cinfa S.A.
Marketing Company Name: Laboratorios Cinfa S.A.
Authorization Date: 2023-06-12
Dosage Form: SOLUCION ORAL EN SOBRE
Dose: 25 mg
Route Of Administration: VÍA ORAL
Prescription Type: Sin Receta
Commercialized: Yes
Company Name: Laboratorios Cinfa S.A.

Active Ingredients

DEXKETOPROFENO TROMETAMOL

36,90 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 12, 2023

Approval ID

88e78556ba8e1c92

Type

Standard

Back to CIMA-AEMPS Approvals